Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,094,118
-
Total 13F shares
-
274,538
-
Share change
-
+235,918
-
Total reported value
-
$1,620,000
-
Price per share
-
$5.90
-
Number of holders
-
9
-
Value change
-
+$1,389,336
-
Number of buys
-
8
-
Number of sells
-
1
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q3 2019
As of 30 Sep 2019,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
274,538 shares.
The largest 9 holders included
Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, Covington Capital Management, VICTORY CAPITAL MANAGEMENT INC, UBS Group AG, Tower Research Capital LLC (TRC), and Advisor Group, Inc..
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.